----- Original Message -----
From: kassy <[email protected]>

> Hi all,
> IP 6 is indeed out and not expensive.  I'm getting mine for
$12.00per
> 120caps @ 500 mg each.  The book IP 6 by AbulKalam M
Shamsuddin, MD PHD is
> a must read.
> ISBN#1-57566-357-0.  This is a very promising product.

Sure does.
IP6 or Phytic acid, a form of insotol, as mentioned by Vilik.
Abundant in cereals and legumes.

Product available here:
http://flourish.future.easyspace.com/ip6/iip6.htm
Research abstracts here:
http://flourish.future.easyspace.com/Ip-6_ab.htm


IP6: A Novel Anti-Cancer Agent
Author(s): Shamsuddin AM, Vucenik I, Cole KE

Source: Life Sciences. 1997; 61(4):343-354.


Abstract:
Inositol hexaphosphate (InsP6 or IP6) is ubiquitous. At 10 µM to
1 mM concentrations, IP6 and its lower phosphorylated forms
(IP1-5) as well as inositol (Ins) are contained in most mammalian
cells, wherein they are important in regulating vital cellular
functions such as signal transduction, cell proliferation and
differentiation. A striking anti-cancer action of IP6 has been
demonstrated both in vivo and in vitro, which is based on the
hypotheses that exogenously administered IP6 may be internalized,
dephosphorylated to IP1-5 and inhibit cell growth. There is
additional evidence that Ins alone may further enhance the
anti-cancer effect of IP6. Besides decreasing cellular
proliferation, IP6 also causes differentiation of malignant cells
often resulting in a reversion to normal phenotype. These data
strongly point towards the involvement of signal transduction
pathways, cell cycle regulatory genes, differentiation genes,
oncogenes and perhaps, tumor suppressor genes in bringing about
the observed anti-neoplastic action of IP6.

Ivan.




--
The silver-list is a moderated forum for discussion of colloidal silver.

To join or quit silver-list or silver-digest send an e-mail message to: 
[email protected]  -or-  [email protected]
with the word subscribe or unsubscribe in the SUBJECT line.

To post, address your message to: [email protected]

List maintainer: Mike Devour <[email protected]>